13F

Stock

Travere Therapeutics, Inc.

TVTX · held by 5 managers

Reported value

$8.96M

Holders

5

+0 new · −0 exited

Holders’ est. mark

−$4.57M

Price effect on 2 books still in the name

Largest holder

$8.02M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC732.5K$8.02M−$4.47MCut−$6.75M
Henshaw Capital LLC34.4K$508.6K−$107.2KCut−$107.2K
Cresset Asset Management, LLC28.9K$427.4KHeld
Essential Partners LLC677$10KHeld

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.